Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells.

Siriboonpiputtana T, Zeisig BB, Zarowiecki M, Fung TK, Mallardo M, Tsai CT, Lau PNI, Hoang QC, Veiga P, Barnes J, Lynn C, Wilson A, Lenhard B, So CWE.

EMBO J. 2017 Nov 2;36(21):3139-3155. doi: 10.15252/embj.201797994. Epub 2017 Oct 4.

PMID:
28978671
2.

Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.

Liang W, Chow MY, Lau PN, Zhou QT, Kwok PC, Leung GP, Mason AJ, Chan HK, Poon LL, Lam JK.

Mol Pharm. 2015 Mar 2;12(3):910-21. doi: 10.1021/mp500745v. Epub 2015 Jan 30.

PMID:
25599953
3.

Spectrum and burden of movement disorder conditions in a tertiary movement disorders centre--a 10-year trend.

Eu KM, Tan LC, Tan AR, Seah IS, Lau PN, Li W, Au WL, Tay KY.

Ann Acad Med Singapore. 2014 Apr;43(4):203-8.

4.

Dynamic localisation of mature microRNAs in Human nucleoli is influenced by exogenous genetic materials.

Li ZF, Liang YM, Lau PN, Shen W, Wang DK, Cheung WT, Xue CJ, Poon LM, Lam YW.

PLoS One. 2013 Aug 6;8(8):e70869. doi: 10.1371/journal.pone.0070869. Print 2013.

5.

Elucidating combinatorial histone modifications and crosstalks by coupling histone-modifying enzyme with biotin ligase activity.

Lau PN, Cheung P.

Nucleic Acids Res. 2013 Feb 1;41(3):e49. doi: 10.1093/nar/gks1247. Epub 2012 Dec 20.

6.

Genogroup I and II picobirnaviruses in respiratory tracts of pigs.

Smits SL, Poon LL, van Leeuwen M, Lau PN, Perera HK, Peiris JS, Simon JH, Osterhaus AD.

Emerg Infect Dis. 2011 Dec;17(12):2328-30. doi: 10.3201/eid1712.110934.

7.

Unlocking polycomb silencing through histone H3 phosphorylation.

Lau PN, Cheung P.

Cell Cycle. 2011 May 15;10(10):1514-5. Epub 2011 May 15. No abstract available.

PMID:
21467844
8.

Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing.

Lau PN, Cheung P.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2801-6. doi: 10.1073/pnas.1012798108. Epub 2011 Jan 31.

9.

Economic burden of Parkinson's disease in Singapore.

Zhao YJ, Tan LC, Li SC, Au WL, Seah SH, Lau PN, Luo N, Wee HL.

Eur J Neurol. 2011 Mar;18(3):519-26. doi: 10.1111/j.1468-1331.2010.03210.x. Epub 2010 Sep 14.

PMID:
20840378
10.

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.

Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, Pica EC, Li SC, Luo N, Tan LC.

Mov Disord. 2010 Apr 30;25(6):710-6. doi: 10.1002/mds.22875.

PMID:
20213822
11.

Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.

Luo N, Ng WY, Lau PN, Au WL, Tan LC.

Qual Life Res. 2010 May;19(4):565-9. doi: 10.1007/s11136-010-9615-7. Epub 2010 Mar 4.

PMID:
20204708
12.

Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.

Luo N, Low S, Lau PN, Au WL, Tan LC.

Ann Acad Med Singapore. 2009 Jun;38(6):521-8.

13.

Cognitive decline in early Parkinson's disease.

Kandiah N, Narasimhalu K, Lau PN, Seah SH, Au WL, Tan LC.

Mov Disord. 2009 Mar 15;24(4):605-8. doi: 10.1002/mds.22384.

PMID:
19191342
14.

The constitutive activity of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent pathway.

Lau PN, Chow KB, Chan CB, Cheng CH, Wise H.

Mol Cell Endocrinol. 2009 Feb 27;299(2):232-9. doi: 10.1016/j.mce.2008.12.006. Epub 2008 Dec 24.

PMID:
19135127
15.

Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8).

Luo N, Tan LC, Zhao Y, Lau PN, Au WL, Li SC.

Mov Disord. 2009 Jan 30;24(2):183-7. doi: 10.1002/mds.22240.

PMID:
18972545
16.

Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index.

Cheung YB, Tan LC, Lau PN, Au WL, Luo N.

Qual Life Res. 2008 Nov;17(9):1173-81. doi: 10.1007/s11136-008-9392-8. Epub 2008 Sep 20.

PMID:
18807209
17.

Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease.

Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N.

Eur J Neurol. 2008 Jul;15(7):737-42. doi: 10.1111/j.1468-1331.2008.02178.x. Epub 2008 May 20.

PMID:
18494793
18.

Monoubiquitylation of H2A.Z distinguishes its association with euchromatin or facultative heterochromatin.

Sarcinella E, Zuzarte PC, Lau PN, Draker R, Cheung P.

Mol Cell Biol. 2007 Sep;27(18):6457-68. Epub 2007 Jul 16.

19.

Validation of PDQ-8 as an independent instrument in English and Chinese.

Tan LC, Lau PN, Au WL, Luo N.

J Neurol Sci. 2007 Apr 15;255(1-2):77-80. Epub 2007 Mar 2.

PMID:
17337275
20.

The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor.

Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH, Wise H.

Cell Signal. 2007 May;19(5):1011-22. Epub 2006 Nov 28.

PMID:
17229547
22.

Use of complementary therapies in patients with Parkinson's disease in Singapore.

Tan LC, Lau PN, Jamora RD, Chan ES.

Mov Disord. 2006 Jan;21(1):86-9.

PMID:
16108030

Supplemental Content

Support Center